Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In Regard to Zietman.
Royce TJ, Tendulkar RD, McBride SM. Royce TJ, et al. Among authors: tendulkar rd. Pract Radiat Oncol. 2021 May-Jun;11(3):e351-e352. doi: 10.1016/j.prro.2020.12.010. Pract Radiat Oncol. 2021. PMID: 33941352 No abstract available.
Long-Term Efficacy and Toxicity of Low-Dose-Rate ¹²⁵I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer.
Kittel JA, Reddy CA, Smith KL, Stephans KL, Tendulkar RD, Ulchaker J, Angermeier K, Campbell S, Stephenson A, Klein EA, Wilkinson DA, Ciezki JP. Kittel JA, et al. Among authors: tendulkar rd. Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):884-93. doi: 10.1016/j.ijrobp.2015.02.047. Epub 2015 May 8. Int J Radiat Oncol Biol Phys. 2015. PMID: 25962627
In Regard to Wu et al.
Tendulkar RD, Ward MC, Suh JH. Tendulkar RD, et al. Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):637. doi: 10.1016/j.ijrobp.2015.11.028. Int J Radiat Oncol Biol Phys. 2016. PMID: 26867893 No abstract available.
Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes.
Kotecha R, Djemil T, Tendulkar RD, Reddy CA, Thousand RA, Vassil A, Stovsky M, Berglund RK, Klein EA, Stephans KL. Kotecha R, et al. Among authors: tendulkar rd. Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):960-964. doi: 10.1016/j.ijrobp.2016.02.009. Epub 2016 Feb 6. Int J Radiat Oncol Biol Phys. 2016. PMID: 27302511 Clinical Trial.
Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific Mortality.
Naik M, Reddy CA, Stephans KL, Ciezki JP, Garcia J, Grivas P, Stephenson AJ, Klein EA, Tendulkar RD. Naik M, et al. Among authors: tendulkar rd. Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):617-23. doi: 10.1016/j.ijrobp.2016.07.009. Epub 2016 Jul 17. Int J Radiat Oncol Biol Phys. 2016. PMID: 27681757
In Reply to Ghadjar et al.
Pisansky TM, Tendulkar RD. Pisansky TM, et al. Among authors: tendulkar rd. Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):439-440. doi: 10.1016/j.ijrobp.2016.10.025. Int J Radiat Oncol Biol Phys. 2017. PMID: 28068253 No abstract available.
119 results